Innovative Technologies Impacted by COVID–19 Act

United States117th CongressHR-9559House of Representatives
Updated: Dec 14, 2022

Summary

Innovative Technologies Impacted by COVID-19 Act This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

All available records shown.